StrokeNet Thrombectomy Endovascular Platform

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1600 participants.

Also called NCT06289985

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06289985
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06289985. Randomized; single masking; primary purpose treatment. Start 2025-01-31 (actual); primary completion 2029-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
StrokeNet Thrombectomy Endovascular Platform
Acronym
STEP
Intervention (Device)
Endovascular thrombectomy with any FDA-approved category POL or NRY device
Intervention (Other)
Medical Management
Lead sponsor
Medical University of South Carolina (class: other)
Collaborator
National Institute of Neurological Disorders and Stroke (NINDS) (class: US National Institutes of Health)
Collaborator
University of Cincinnati (class: other)
Collaborator
University of Virginia (class: other)
Collaborator
Berry Consultants (class: other)
Collaborator
University of California, Los Angeles (class: other)
Collaborator
MOUNT SINAI HOSPITAL (class: other)
Collaborator
Cooper Norcross Health (class: other)
Collaborator
University of Pittsburgh Medical Center (class: other)
Collaborator
Stony Brook University (class: other)
Collaborator
University at Buffalo (class: other)

Record details

Record id
cardio:ct-nct06289985
Content hash
bf1af23f8e63a56a1cf16eed77884d197b937e9d36bea072c20a7632cee1f01b